Skip to Content

NVR ABL (Tasigna 50 mg)

Generic Name: nilotinib

Pill with imprint NVR ABL is Red & Yellow, Capsule-shape and has been identified as Tasigna 50 mg.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR ABL

Tasigna 50 mg NVR ABL

Tasigna

Generic Name:
nilotinib
Imprint:
NVR ABL
Strength:
50 mg
Color:
Red & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0951

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide